These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29946510)

  • 1.
    Faber I; Martinez ARM; de Rezende TJR; Martins CR; Martins MP; Lourenço CM; Marques W; Montecchiani C; Orlacchio A; Pedroso JL; Barsottini OGP; Lopes-Cendes Í; França MC
    Neuroimage Clin; 2018; 19():848-857. PubMed ID: 29946510
    [No Abstract]   [Full Text] [Related]  

  • 2. White and grey matter abnormalities in patients with SPG11 mutations.
    França MC; Yasuda CL; Pereira FR; D'Abreu A; Lopes-Ramos CM; Rosa MV; Cendes F; Lopes-Cendes I
    J Neurol Neurosurg Psychiatry; 2012 Aug; 83(8):828-33. PubMed ID: 22696581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor imaging in SPG11- and SPG4-linked hereditary spastic paraplegia.
    Garaci F; Toschi N; Lanzafame S; Meschini A; Bertini E; Simonetti G; Santorelli FM; Guerrisi M; Floris R
    Int J Neurosci; 2014 Apr; 124(4):261-70. PubMed ID: 23968121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Damage and Gene Expression Across Hereditary Spastic Paraplegia Subtypes.
    Servelhere KR; Rezende TJR; de Lima FD; de Brito MR; de França Nunes RF; Casseb RF; Pedroso JL; Barsottini OGP; Cendes F; França MC
    Mov Disord; 2021 Jul; 36(7):1644-1653. PubMed ID: 33576112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monozygotic twins with a new compound heterozygous SPG11 mutation and different disease expression.
    Schneider-Gold C; Dekomien G; Regensburger M; Schneider R; Trampe N; Krogias C; Lukas C; Bellenberg B
    J Neurol Sci; 2017 Oct; 381():265-268. PubMed ID: 28991695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes.
    Castellano A; Papinutto N; Cadioli M; Brugnara G; Iadanza A; Scigliuolo G; Pareyson D; Uziel G; Köhler W; Aubourg P; Falini A; Henry RG; Politi LS; Salsano E
    Brain; 2016 Jun; 139(Pt 6):1735-46. PubMed ID: 27068048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal MRI-based study in patients with SPG4 mutations.
    Rezende TJ; de Albuquerque M; Lamas GM; Martinez AR; Campos BM; Casseb RF; Silva CB; Branco LM; D'Abreu A; Lopes-Cendes I; Cendes F; França MC
    PLoS One; 2015; 10(2):e0117666. PubMed ID: 25658484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tract-based spatial statistics of diffusion tensor imaging in hereditary spastic paraplegia with thin corpus callosum reveals widespread white matter changes.
    Oğuz KK; Sanverdi E; Has A; Temuçin Ç; Türk S; Doerschner K
    Diagn Interv Radiol; 2013; 19(3):181-6. PubMed ID: 23302284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel SPG11 mutations in Chinese families with hereditary spastic paraplegia with thin corpus callosum.
    Cao L; Rong TY; Huang XJ; Fang R; Wu ZY; Tang HD; Chen SD
    Parkinsonism Relat Disord; 2013 Mar; 19(3):367-70. PubMed ID: 23121729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tensor-based morphometry using scalar and directional information of diffusion tensor MRI data (DTBM): Application to hereditary spastic paraplegia.
    Sadeghi N; Arrigoni F; D'Angelo MG; Thomas C; Irfanoglu MO; Hutchinson EB; Nayak A; Modi P; Bassi MT; Pierpaoli C
    Hum Brain Mapp; 2018 Dec; 39(12):4643-4651. PubMed ID: 30253021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations.
    Lindig T; Bender B; Hauser TK; Mang S; Schweikardt D; Klose U; Karle KN; Schüle R; Schöls L; Rattay TW
    J Neurol; 2015 Aug; 262(8):1961-71. PubMed ID: 26050637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Compound Heterozygous Spatacsin Mutations in a Greek Kindred with Hereditary Spastic Paraplegia SPG11 and Dementia.
    Fraidakis MJ; Brunetti M; Blackstone C; Filippi M; Chiò A
    Neurodegener Dis; 2016; 16(5-6):373-81. PubMed ID: 27318863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and phenotypic characterization of complex hereditary spastic paraplegia.
    Kara E; Tucci A; Manzoni C; Lynch DS; Elpidorou M; Bettencourt C; Chelban V; Manole A; Hamed SA; Haridy NA; Federoff M; Preza E; Hughes D; Pittman A; Jaunmuktane Z; Brandner S; Xiromerisiou G; Wiethoff S; Schottlaender L; Proukakis C; Morris H; Warner T; Bhatia KP; Korlipara LV; Singleton AB; Hardy J; Wood NW; Lewis PA; Houlden H
    Brain; 2016 Jul; 139(Pt 7):1904-18. PubMed ID: 27217339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between brain white matter damage and grey matter atrophy in hereditary spastic paraplegia types 4 and 5.
    Tu Y; Liu Y; Fan S; Weng J; Li M; Zhang F; Fu Y; Hu J
    Eur J Neurol; 2024 Aug; 31(8):e16310. PubMed ID: 38651515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal Cord Gray and White Matter Damage in Different Hereditary Spastic Paraplegia Subtypes.
    Servelhere KR; Casseb RF; de Lima FD; Rezende TJR; Ramalho LP; França MC
    AJNR Am J Neuroradiol; 2021 Mar; 42(3):610-615. PubMed ID: 33478946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPG11 mutations cause Kjellin syndrome, a hereditary spastic paraplegia with thin corpus callosum and central retinal degeneration.
    Orlén H; Melberg A; Raininko R; Kumlien E; Entesarian M; Söderberg P; Påhlman M; Darin N; Kyllerman M; Holmberg E; Engler H; Eriksson U; Dahl N
    Am J Med Genet B Neuropsychiatr Genet; 2009 Oct; 150B(7):984-92. PubMed ID: 19194956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern reversal visual evoked potentials (prVEPs) in autosomal recessive hereditary spastic paraplegia with thin corpus callosum (ARHSPTCC) patients with SPG 11 mutations in Saudi Arabia, cross section hospital base study.
    Alfaidi N; Sobahy T; Ali Q; Al Said Y; Karim G; Khan H; Kurdi K; Cupler E
    J Neurol Sci; 2022 Mar; 434():120144. PubMed ID: 35074613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration.
    Stevanin G; Azzedine H; Denora P; Boukhris A; Tazir M; Lossos A; Rosa AL; Lerer I; Hamri A; Alegria P; Loureiro J; Tada M; Hannequin D; Anheim M; Goizet C; Gonzalez-Martinez V; Le Ber I; Forlani S; Iwabuchi K; Meiner V; Uyanik G; Erichsen AK; Feki I; Pasquier F; Belarbi S; Cruz VT; Depienne C; Truchetto J; Garrigues G; Tallaksen C; Tranchant C; Nishizawa M; Vale J; Coutinho P; Santorelli FM; Mhiri C; Brice A; Durr A;
    Brain; 2008 Mar; 131(Pt 3):772-84. PubMed ID: 18079167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autopsied case report of spastic paraplegia with thin corpus callosum carrying a novel mutation in the SPG11 gene: widespread degeneration with eosinophilic inclusions.
    Hayakawa M; Matsubara T; Mochizuki Y; Takeuchi C; Minamitani M; Imai M; Kosaki K; Arai T; Murayama S
    BMC Neurol; 2022 Jan; 22(1):2. PubMed ID: 34979968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychology and MRI correlates of neurodegeneration in SPG11 hereditary spastic paraplegia.
    Utz KS; Kohl Z; Marterstock DC; Doerfler A; Winkler J; Schmidt M; Regensburger M
    Orphanet J Rare Dis; 2022 Jul; 17(1):301. PubMed ID: 35906604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.